Retatrutide is a synthetic triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, developed for investigative metabolic research.
FOR RESEARCH AND LABORATORY USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT FOR MEDICAL, VETERINARY, OR HOUSEHOLD USE.
Pure Research Peptides LLC provides this compound strictly for in-vitro laboratory research purposes. No statements on this site have been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for compliance with all applicable laws and regulations.
All products currently listed on this site are for research purposes only.





